A Phase 3, Double-blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Mitapivat in Subjects With Non–Transfusion-Dependent Alpha or Beta Thalassemia (ENERGIZE)
2022-11-27
عنوان الدراسة
A Phase 3, Double-blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Mitapivat in Subjects With Non–Transfusion-Dependent Alpha or Beta Thalassemia (ENERGIZE)
داعم الدراسة
Agios Pharmaceuticals, Inc.
دواء الدراسة
Mitapivat
رقم بروتوكول الدراسة
AG348-C-017
حالة الدراسة
Ongoing
موقع الدراسة
King Khalid University Hospital (Riyadh),King Abdulaziz Medical City NG (Riyadh),King Abdulaziz Hospital NG (Al Ahsa)
مرحلة الدراسة
3
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。